Atul Ltd
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. [1]
Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms. [2]
- Market Cap ₹ 16,178 Cr.
- Current Price ₹ 5,495
- High / Low ₹ 8,180 / 5,175
- Stock P/E 38.9
- Book Value ₹ 1,905
- Dividend Yield 0.36 %
- ROCE 8.74 %
- ROE 6.35 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 2.88 times its book value
- The company has delivered a poor sales growth of 3.20% over past five years.
- Company has a low return on equity of 10.5% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 250 SmallCap Index BSE SmallCap Select Index BSE 400 MidSmallCap Index Nifty Smallcap 50 Nifty 500 Multicap 50:25:25
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,029 | 2,439 | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,344 | |
1,780 | 2,075 | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,086 | 4,506 | |
Operating Profit | 249 | 364 | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 639 | 838 |
OPM % | 12% | 15% | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 14% | 16% |
22 | 36 | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 82 | 86 | 65 | 86 | |
Interest | 33 | 33 | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 |
Depreciation | 51 | 58 | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 311 |
Profit before tax | 186 | 308 | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 589 |
Tax % | 31% | 29% | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% | |
120 | 219 | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 427 | |
EPS in Rs | 40.38 | 73.90 | 81.13 | 92.44 | 108.88 | 93.21 | 145.72 | 224.69 | 221.64 | 204.23 | 174.19 | 109.71 | 141.24 |
Dividend Payout % | 15% | 10% | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 3% |
3 Years: | 8% |
TTM: | 13% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | -6% |
3 Years: | -21% |
TTM: | 17% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 2% |
3 Years: | -16% |
1 Year: | -13% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 14% |
3 Years: | 10% |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 |
Reserves | 725 | 919 | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,579 |
370 | 367 | 299 | 316 | 168 | 16 | 55 | 108 | 133 | 144 | 52 | 237 | 217 | |
440 | 502 | 485 | 535 | 591 | 749 | 783 | 880 | 976 | 1,117 | 1,028 | 1,104 | 1,332 | |
Total Liabilities | 1,564 | 1,818 | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 7,158 |
506 | 570 | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,110 | 1,418 | 1,634 | 1,770 | 2,792 | 2,816 | |
CWIP | 66 | 59 | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 | 212 |
Investments | 67 | 63 | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 | 1,693 |
925 | 1,126 | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,528 | 1,906 | 2,297 | 2,068 | 1,990 | 2,437 | |
Total Assets | 1,564 | 1,818 | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 7,158 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
187 | 152 | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | |
-116 | -83 | -167 | -375 | -175 | -129 | -408 | -782 | -645 | -163 | -469 | -683 | |
-78 | -60 | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | |
Net Cash Flow | -6 | 8 | 16 | -13 | 5 | 19 | -5 | -11 | 21 | 11 | -20 | 22 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 63 | 65 | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 |
Inventory Days | 116 | 119 | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 |
Days Payable | 92 | 89 | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 |
Cash Conversion Cycle | 87 | 95 | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 |
Working Capital Days | 71 | 76 | 75 | 82 | 84 | 78 | 75 | 60 | 68 | 83 | 69 | 70 |
ROCE % | 20% | 28% | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% | 9% |
Documents
Announcements
-
Update On Valsad Institute Of Medical Sciences Ltd
13 Feb - Update on acquisition of Valsad Institute of Medical Sciences.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 6 Feb
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 4 Feb
-
Communication To The Members Of The Company Regarding Financial Results And Investors' Presentation For The Third Quarter And Nine Months Ended On December 31, 2024
27 Jan - Financial results for Q3 and nine months ended December 31, 2024.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 25 Jan
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
-
Financial Year 2011
from bse
History
The company is a part of Lalbhai Group, one of the oldest business houses in India and the first company in India inaugurated by the first Prime Minister. It was originally promoted by Padma Bhushan late Kasturbhai Lalbhai in 1947 as Atul Products Ltd and was later renamed Atul Ltd in 1996. It has followed the B2B model since inception, it has now also ventured into B2C products. [1] [2]